» Articles » PMID: 18334594

Accuracy of Diagnostic Tests for Cushing's Syndrome: a Systematic Review and Metaanalyses

Overview
Specialty Endocrinology
Date 2008 Mar 13
PMID 18334594
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The diagnosis of Cushing's syndrome (CS) requires the use of tests of unregulated hypercortisolism that have unclear accuracy.

Objective: Our objective was to summarize evidence on the accuracy of common tests for diagnosing CS.

Data Sources: We searched electronic databases (MEDLINE, EMBASE, Web of Science, Scopus, and citation search for key articles) from 1975 through September 2007 and sought additional references from experts.

Study Selection: Eligible studies reported on the accuracy of urinary free cortisol (UFC), dexamethasone suppression test (DST), and midnight cortisol assays vs. reference standard in patients suspected of CS.

Data Extraction: Reviewers working in duplicate and independently extracted study characteristics and quality and data to estimate the likelihood ratio (LR) and the 95% confidence interval (CI) for each result.

Data Synthesis: We found 27 eligible studies, with a high prevalence [794 (9.2%) of 8631 patients had CS] and severity of CS. The tests had similar accuracy: UFC (n = 14 studies; LR+ 10.6, CI 5.5-20.5; LR- 0.16, CI 0.08-0.33), salivary midnight cortisol (n = 4; LR+ 8.8, CI 3.5-21.8; LR- 0.07, CI 0-1.2), and the 1-mg overnight DST (n = 14; LR+ 16.4, CI 9.3-28.8; LR- 0.06, CI 0.03-0.14). Combined testing strategies (e.g. a positive result in both UFC and 1-mg overnight DST) had similar diagnostic accuracy (n = 3; LR+ 15.4, CI 0.7-358; LR- 0.11, CI 0.007-1.57).

Conclusions: Commonly used tests to diagnose CS appear highly accurate in referral practices with samples enriched with patients with CS. Their performance in usual clinical practice remains unclear.

Citing Articles

Cushing syndrome.

Nieman L, Castinetti F, Newell-Price J, Valassi E, Drouin J, Takahashi Y Nat Rev Dis Primers. 2025; 11(1):4.

PMID: 39848955 DOI: 10.1038/s41572-024-00588-w.


Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.

Efthymiadis A, Loo H, Shine B, James T, Keevil B, Tomlinson J J Endocrinol Invest. 2024; 47(10):2449-2459.

PMID: 38536658 PMC: 11393038. DOI: 10.1007/s40618-024-02354-x.


Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing's syndrome - a single-center retrospective cohort study.

Ardakani M, Rabizadeh S, Yadegar A, Mohammadi F, Karimpour Reyhan S, Qahremani R BMC Endocr Disord. 2023; 23(1):232.

PMID: 37872539 PMC: 10591461. DOI: 10.1186/s12902-023-01495-z.


Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.

Zhou Y, Zhang A, Fang C, Yuan L, Shao A, Xu Y CNS Neurosci Ther. 2023; 29(10):2744-2759.

PMID: 37341156 PMC: 10493678. DOI: 10.1111/cns.14315.


The promising role of risk scoring system for Cushing syndrome: Time to reconsider current screening recommendations.

Lam-Chung C, Cuevas-Ramos D Front Endocrinol (Lausanne). 2022; 13:1075785.

PMID: 36482998 PMC: 9725023. DOI: 10.3389/fendo.2022.1075785.